S&P 500   3,790.93 (+3.06%)
DOW   30,316.32 (+2.80%)
QQQ   282.13 (+3.14%)
AAPL   146.10 (+2.56%)
MSFT   248.88 (+3.38%)
META   140.28 (+1.20%)
GOOGL   101.64 (+3.04%)
AMZN   121.09 (+4.50%)
TSLA   249.44 (+2.90%)
NVDA   131.67 (+5.23%)
NIO   16.73 (+8.01%)
BABA   84.11 (+4.55%)
AMD   67.90 (+2.71%)
T   16.09 (+1.19%)
MU   53.96 (+4.33%)
CGC   3.14 (+7.90%)
F   12.36 (+7.76%)
GE   67.54 (+6.19%)
DIS   101.44 (+4.44%)
AMC   7.83 (+13.81%)
PYPL   92.79 (+6.43%)
PFE   44.46 (+0.72%)
NFLX   240.74 (+0.71%)
S&P 500   3,790.93 (+3.06%)
DOW   30,316.32 (+2.80%)
QQQ   282.13 (+3.14%)
AAPL   146.10 (+2.56%)
MSFT   248.88 (+3.38%)
META   140.28 (+1.20%)
GOOGL   101.64 (+3.04%)
AMZN   121.09 (+4.50%)
TSLA   249.44 (+2.90%)
NVDA   131.67 (+5.23%)
NIO   16.73 (+8.01%)
BABA   84.11 (+4.55%)
AMD   67.90 (+2.71%)
T   16.09 (+1.19%)
MU   53.96 (+4.33%)
CGC   3.14 (+7.90%)
F   12.36 (+7.76%)
GE   67.54 (+6.19%)
DIS   101.44 (+4.44%)
AMC   7.83 (+13.81%)
PYPL   92.79 (+6.43%)
PFE   44.46 (+0.72%)
NFLX   240.74 (+0.71%)
S&P 500   3,790.93 (+3.06%)
DOW   30,316.32 (+2.80%)
QQQ   282.13 (+3.14%)
AAPL   146.10 (+2.56%)
MSFT   248.88 (+3.38%)
META   140.28 (+1.20%)
GOOGL   101.64 (+3.04%)
AMZN   121.09 (+4.50%)
TSLA   249.44 (+2.90%)
NVDA   131.67 (+5.23%)
NIO   16.73 (+8.01%)
BABA   84.11 (+4.55%)
AMD   67.90 (+2.71%)
T   16.09 (+1.19%)
MU   53.96 (+4.33%)
CGC   3.14 (+7.90%)
F   12.36 (+7.76%)
GE   67.54 (+6.19%)
DIS   101.44 (+4.44%)
AMC   7.83 (+13.81%)
PYPL   92.79 (+6.43%)
PFE   44.46 (+0.72%)
NFLX   240.74 (+0.71%)
S&P 500   3,790.93 (+3.06%)
DOW   30,316.32 (+2.80%)
QQQ   282.13 (+3.14%)
AAPL   146.10 (+2.56%)
MSFT   248.88 (+3.38%)
META   140.28 (+1.20%)
GOOGL   101.64 (+3.04%)
AMZN   121.09 (+4.50%)
TSLA   249.44 (+2.90%)
NVDA   131.67 (+5.23%)
NIO   16.73 (+8.01%)
BABA   84.11 (+4.55%)
AMD   67.90 (+2.71%)
T   16.09 (+1.19%)
MU   53.96 (+4.33%)
CGC   3.14 (+7.90%)
F   12.36 (+7.76%)
GE   67.54 (+6.19%)
DIS   101.44 (+4.44%)
AMC   7.83 (+13.81%)
PYPL   92.79 (+6.43%)
PFE   44.46 (+0.72%)
NFLX   240.74 (+0.71%)
NYSE:ALB

Albemarle - ALB Stock Forecast, Price & News

$283.78
+10.05 (+3.67%)
(As of 10/4/2022 12:00 AM ET)
Add
Compare
Today's Range
$278.70
$289.05
50-Day Range
$225.10
$307.05
52-Week Range
$169.93
$308.24
Volume
1.25 million shs
Average Volume
1.26 million shs
Market Capitalization
$33.24 billion
P/E Ratio
127.83
Dividend Yield
0.58%
Price Target
$287.45

Albemarle MarketRank™ Forecast

Analyst Rating
Hold
2.47 Rating Score
Upside/​Downside
4.2% Upside
$295.79 Price Target
Short Interest
Healthy
2.31% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-6.52
Upright™ Environmental Score
News Sentiment
0.49mentions of Albemarle in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$609,188 Sold Last Quarter
Proj. Earnings Growth
22.76%
From $21.22 to $26.05 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.59 out of 5 stars

Basic Materials Sector

46th out of 166 stocks

Plastics Materials & Resins Industry

5th out of 11 stocks

ALB stock logo

About Albemarle (NYSE:ALB) Stock

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Receive ALB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Albemarle and its competitors with MarketBeat's FREE daily newsletter.

ALB Stock News Headlines

Bull of the Day: Albemarle (ALB)
Albemarle Announces New Global Business Unit Alignment
Albemarle Corporation: Raising price target to $366
Albemarle To $440? Here Are 5 Other Price Target Changes For Monday
See More Headlines
Receive ALB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Albemarle and its competitors with MarketBeat's FREE daily newsletter.

ALB Company Calendar

Last Earnings
8/03/2022
Ex-Dividend for 10/3 Dividend
9/15/2022
Dividend Payable
10/03/2022
Today
10/04/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Plastics materials & resins
Sub-Industry
Specialty Chemicals
CUSIP
01265310
Employees
6,000
Year Founded
1994

Price Target and Rating

Average Stock Price Forecast
$295.79
High Stock Price Forecast
$440.00
Low Stock Price Forecast
$196.00
Forecasted Upside/Downside
+1.3%
Consensus Rating
Hold
Rating Score (0-4)
2.47
Research Coverage
14 Analysts

Profitability

Net Income
$123.67 million
Pretax Margin
4.07%

Debt

Sales & Book Value

Annual Sales
$3.33 billion
Cash Flow
$6.64 per share
Book Value
$49.63 per share

Miscellaneous

Free Float
116,836,000
Market Cap
$33.24 billion
Optionable
Optionable
Beta
1.44

Social Links


Key Executives

  • Mr. Jerry Kent Masters Jr.Mr. Jerry Kent Masters Jr. (Age 61)
    Chairman, Pres & CEO
    Comp: $3.49M
  • Mr. Scott A. TozierMr. Scott A. Tozier (Age 56)
    Exec. VP & CFO
    Comp: $1.55M
  • Ms. Karen G. Narwold Esq.Ms. Karen G. Narwold Esq. (Age 62)
    Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec.
    Comp: $1.32M
  • Mr. Eric W. NorrisMr. Eric W. Norris (Age 55)
    Pres of Lithium Global Bus. Unit
    Comp: $1.47M
  • Mr. Netha N. Johnson Jr.Mr. Netha N. Johnson Jr. (Age 51)
    Pres of Bromine Specialties Global Bus. Unit
    Comp: $1.28M
  • Mr. John Clarence Barichivich III (Age 54)
    VP, Corp. Controller & Chief Accounting Officer
  • Mr. Patrick Thompson
    Chief Information Officer
  • Ms. Melissa H. Anderson (Age 57)
    Sr. VP & Chief HR Officer
  • Mr. Ahmad Khalifeh
    Managing Director of Middle East Office
  • Mr. Raphael Goszcz CrawfordMr. Raphael Goszcz Crawford (Age 46)
    Pres of Catalysts Global Bus. Unit













ALB Stock - Frequently Asked Questions

Should I buy or sell Albemarle stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ALB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.
View ALB analyst ratings
or view top-rated stocks.

What is Albemarle's stock price forecast for 2022?

14 brokerages have issued 12 month target prices for Albemarle's stock. Their ALB share price forecasts range from $196.00 to $440.00. On average, they predict the company's share price to reach $295.79 in the next twelve months. This suggests a possible upside of 4.2% from the stock's current price.
View analysts price targets for ALB
or view top-rated stocks among Wall Street analysts.

How have ALB shares performed in 2022?

Albemarle's stock was trading at $233.77 at the start of the year. Since then, ALB stock has increased by 21.4% and is now trading at $283.78.
View the best growth stocks for 2022 here
.

Are investors shorting Albemarle?

Albemarle saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 2,710,000 shares, an increase of 10.6% from the August 31st total of 2,450,000 shares. Based on an average daily trading volume, of 1,280,000 shares, the days-to-cover ratio is currently 2.1 days.
View Albemarle's Short Interest
.

When is Albemarle's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our ALB earnings forecast
.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) issued its quarterly earnings results on Wednesday, August, 3rd. The specialty chemicals company reported $3.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.03 by $0.42. The specialty chemicals company had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.37 billion. Albemarle had a trailing twelve-month return on equity of 15.39% and a net margin of 6.08%. During the same period in the prior year, the firm posted $0.89 earnings per share.
Read the conference call transcript
.

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle declared a quarterly dividend on Monday, July 18th. Stockholders of record on Friday, September 16th will be given a dividend of $0.395 per share on Monday, October 3rd. This represents a $1.58 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date of this dividend is Thursday, September 15th.
Read our dividend analysis for ALB
.

Is Albemarle a good dividend stock?

Albemarle (NYSE:ALB) pays an annual dividend of $1.58 per share and currently has a dividend yield of 0.58%. The company has been increasing its dividend for 28 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 71.17%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALB will have a dividend payout ratio of 6.07% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALB.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share guidance of $19.25-$22.25 for the period, compared to the consensus EPS estimate of $13.65. The company issued revenue guidance of $7.10 billion-$7.50 billion, compared to the consensus revenue estimate of $6.00 billion.

What is Luther C. Kissam, IV's approval rating as Albemarle's CEO?

63 employees have rated Albemarle Chief Executive Officer Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among the company's employees.

What other stocks do shareholders of Albemarle own?
What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Who are Albemarle's major shareholders?

Albemarle's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Red Spruce Capital LLC (0.01%), AdvisorNet Financial Inc (0.00%), Fulton Bank N.A. (0.00%), Confluence Investment Management LLC (0.00%) and Wedmont Private Capital (0.00%). Insiders that own company stock include Eric Norris, J Kent Masters, John Clarence Barichivich III, Karen G Narwold, Karen G Narwold, Luther C Iv Kissam, Netha N Johnson, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends
.

How do I buy shares of Albemarle?

Shares of ALB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $283.78.

How much money does Albemarle make?

Albemarle (NYSE:ALB) has a market capitalization of $33.24 billion and generates $3.33 billion in revenue each year. The specialty chemicals company earns $123.67 million in net income (profit) each year or $2.22 on an earnings per share basis.

How many employees does Albemarle have?

The company employs 6,000 workers across the globe.

Does Albemarle have any subsidiaries?
The following companies are subsidiares of Albemarle: ACI Cyprus L.L.C., Albemarle (Thailand) Co. Ltd., Albemarle Argentina S.R.L., Albemarle Brazil Holdings LTDA., Albemarle Care Fund, Albemarle Catalysts Company B.V., Albemarle Chemical Canada Ltd., Albemarle Chemicals (Shanghai) Co. Ltd., Albemarle Chemicals Ltd, Albemarle Chemicals Private Limited, Albemarle Chemicals SAS, Albemarle Chemicals South Africa (Proprietary) Limited, Albemarle Delaware Holdings 1 LLC, Albemarle Delaware Holdings 2 LLC, Albemarle Dutch Holdings 2 B.V., Albemarle Dutch Holdings B.V., Albemarle Europe SRL, Albemarle Finance Company B.V., Albemarle Foundation, Albemarle Germany Gmbh, Albemarle Hilfe GmbH Unterstützungskasse, Albemarle Holdings Company Limited, Albemarle Holdings Limited, Albemarle Hungary Ltd., Albemarle Italy S.R.L., Albemarle Japan Corporation, Albemarle Japan Holdings B.V., Albemarle Knight Lux 1 Holdings Corporation, Albemarle Korea Corporation, Albemarle Limitada, Albemarle Lithium (Jiangsu) Co. Ltd., Albemarle Lithium Holding Corporation, Albemarle Lithium Holding GmbH, Albemarle Lithium Pty Ltd, Albemarle Lithium UK Limited, Albemarle Malaysia Sdn Bhd., Albemarle Management (Shanghai) Co. Ltd., Albemarle Middle East FZE, Albemarle Netherlands B.V., Albemarle New Holding GmbH, Albemarle Overseas Employment Corporation, Albemarle Qúimica Ltda., Albemarle Saudi Trading Company, Albemarle Sichuan New Materials Co. Ltd., Albemarle Singapore Pte. Ltd., Albemarle Spain S.L., Albemarle Taiwan Limited, Albemarle U.S. Inc., Albemarle Vietnam Limited Liability Company, Albemarle Wodgina Pty Ltd, Albemarle de Venezuela C.A., Dynamit Nobel GmbH, Dynamit Nobel Unterstützungsfonds GmbH, Excalibur II Realty Company, Excalibur Realty Company, Foote Chile Holding Company, Foote Minera e Inversiones Limitada, Jiangxi Albemarle Lithium Co. Ltd., Jordan Bromine Company Ltd., Knight Lux 1 S.à r.l., Knight Lux 2 S.à r.l., MARBL Lithium Operations Pty Ltd, MRL’s Wodgina Project, Metalon Environmental Management & Solutions GmbH, PT Albemarle Chemicals Indonesia, RSG Immobilien GmbH, RT Lithium Limited, Rockwood Holdings, Rockwood Holdings Inc., Rockwood Lithium (Shanghai) Co. Ltd., Rockwood Lithium India Private Limited, Rockwood Lithium Japan K.K., Rockwood Lithium Korea LLC, Rockwood Lithium Taiwan Co. Ltd., Rockwood Specialties GmbH, Rockwood Specialties Group LLC, Rockwood Specialties LLC, Rockwood Specialties Limited, Sales de Magnesio Limitada, Shandong Sinobrom Albemarle Bromine Chemicals Company Limited, and Sichuan Guorun New Material Co. Ltd..
Read More
How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The official website for the company is www.albemarle.com. The specialty chemicals company can be reached via phone at (980) 299-5700, via email at invest@albemarle.com, or via fax at 225-388-7686.

This page (NYSE:ALB) was last updated on 10/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.